Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Int J Mol Med. 2007 Dec;20(6):783–792.

Table I.

Initial and final body weights and blood glucose concentrations in control mice and diabetic mice with and without the peroxynitrite decomposition catalyst FeTMPS treatment.

Body weight (g)
Blood glucose (mmol/l)
Initial Final Initial Final
Control 20.6±0.40 29.0±0.95 7.90±0.17 8.00±0.20
Control + FeTMPS (5 mg/kg/day) 20.3±0.50 27.0±0.70 7.70±0.33 7.90±0.12
Control + FeTMPS (10 mg/kg/day) 20.7±0.47 28.0±0.90 8.35±0.27 8.05±0.24
Diabetic 20.2±0.33 24.9±0.53a 14.40±0.70a 33.00±0.20a
Diabetic + FeTMPS (5 mg/kg/day) 20.9±0.33 25.0±0.40a 15.30±0.70a 32.40±0.50a
Diabetic + FeTMPS (10 mg/kg/day) 20.6±0.60 24.6±0.80a 14.20±0.90a 32.60±0.40a

Data are the means ± SEM, n=8–14 per group.

a

Significantly different from the controls (p<0.01)